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Abstract
Protein translation has been implicated in different forms of synaptic plasticity but direct in situ 
visualization of new proteins is limited to one or two proteins at a time. Here we describe a 
metabolic labeling approach based upon incorporation of non-canonical amino acids into proteins 
followed by chemo–selective fluorescent tagging via click chemistry. Following brief incubation 
with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in 
somata and dendrites. Pulse–chase–like application of azidohomoalanine and 
homopropargylglycine allowed visualization of proteins synthesized in two sequential time 
periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate 
of proteins synthesized in different cellular compartments. Moreover, using strain–promoted 
cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single 
particle tracking and quantum dots. The newly synthesized proteins exhibited a broad range of 
diffusive behaviors as expected if the pool of labeled proteins was heterogeneous.
Introduction
The visualization of a newly synthesized proteome has been hindered so far by the fact that 
proteins, new and old, share the same pool of amino acids and thus are chemically 
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indistinguishable. Radioisotopic amino acids can provide potent labeling of newly 
synthesized proteins but the subsequent visualization of new proteomes in intact cells is not 
well–resolved or amenable to current fluorescence microscopy techniques.
The proteome of a neuron is a dynamic entity – tightly regulated by protein synthesis and 
degradation to maintain homeostasis or to adapt to changing environmental conditions. 
Many studies of behavioral and synaptic plasticity have demonstrated that long–lasting 
changes in synaptic transmission and behavior require both gene transcription and mRNA 
translation (reviewed in ref.1). Indeed, a distinguishing feature of late–phase long–term 
potentiation is that it requires both gene transcription and mRNA translation (e.g. ref.2). 
Protein synthesis occurs in somata, as well as in the protrusions of neurons and other 
polarized cells. In neurons, there is abundant evidence from both in vivo and in vitro 
experiments that dendritic protein synthesis is used to allow neuronal synapses to respond 
dynamically and in a specifically local way to the stimulation patterns that drive the 
establishment, maintenance and plasticity of synaptic connections3–6. Moreover, several 
studies have demonstrated that different biochemical fractions, which lack somatic protein 
synthesis machinery are nonetheless capable of synthesizing proteins (see refs.7, 8 for 
review), and several proteomics studies have identified proteins belonging to different 
functional classes9–11. Despite overwhelming support for the general notion of dendritic 
protein translation in plasticity and synaptic function, local protein translation has been 
monitored so far for only a few candidate proteins. Visualization of newly synthesized 
proteins in neurons has largely relied on the use of green fluorescent protein GFP– either as 
a fusion with the protein of interest or with the coding sequence for GFP flanked by the 5’ 
and 3’ UTRs (to confer regulation of mRNA translation) of the protein of interest12–14 – or 
a protease–controlled tag15. All of these approaches require over–expression of the coding 
sequence and/or the regulatory regions of the mRNA. The ability to visualize the pool of 
newly synthesized endogenous proteins has been hampered by the fact that all proteins share 
the same pool of 20 amino acids. However, recent work16–19 has expanded the natural 
repertoire of amino acids and introduced small, bioorthogonal groups that are metabolically 
incorporated into nascent proteins, enabling one to pulse label a set of new proteins20.
We recently described the use of the azide–bearing amino acid azidohomoalanine (AHA) or 
the alkyne–bearing amino acid homopropargylglycine (HPG) for incorporation into new 
proteins by making use of the cell’s own protein synthesis machinery; this technology is 
called BONCAT, BioOrthogonal Non–Canonical Amino acid Tagging21,22). In BONCAT 
the methionine surrogate AHA is incorporated into newly synthesized proteins at methionine 
codons and subsequently tagged with an alkyne–affinity tag via copper–catalyzed azide–
alkyne [3+2] cycloaddition (CuAAC;23) for the ultimate identification of AHA–labeled 
proteins using mass spectrometry. Here, we introduce, using a new generation of fluorescent 
tags, a sister technology to BONCAT that labels and enables the visualization of a broad 
spectrum of newly synthesized neuronal proteins in situ using conventional fluorescence 
microscopy. We name this visualization approach FUNCAT (FlUorescent Non–Canonical 
Amino acid Tagging).
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Results
Fluorescent in situ tagging of newly synthesized proteins
Given limited current methods, we sought to develop a methodology for the in situ 
visualization of newly synthesized proteins using fluorescence microscopy. Building on the 
core chemistry of BONCAT, we synthesized two different fluorescent tags (TexasRed–
PEO2–Alkyne, TRA; 5’–carboxyfluorescein–PEO8–Azide, FLA) that can be coupled to 
AHA– or HPG–bearing proteins using click chemistry23 (Fig. 1a,b; Supplementary Fig. 1). 
For the tag synthesis, the use of the water soluble linker polyethylene oxide (PEO) simplifies 
the synthesis, making it tractable in a biology laboratory setting18, and also maximizes the 
signal–to–noise ratio of the fluorescent labeling as any unligated tag is easily removed by 
washes.
We optimized the labeling and reaction conditions to maximize the specific detection of 
newly synthesized proteins in situ and to permit immunolabeling. To maximize charging and 
incorporation of the methionine surrogates AHA or HPG, we removed growth media from 
the preparations and replaced it with HBS or HibA media for 30 min prior addition of AHA 
or HPG. Following bath application of either AHA or HPG, we fixed and permeabilized 
neurons using Triton X–100. After overnight incubation in a reaction mixture that included 
the fluorescent tag, the copper catalyst and the triazole ligand, we visualized (Fig. 1b), 
newly synthesized proteins using conventional fluorescence microscopy. Incubation of 
primary hippocampal neurons with AHA or HPG for 1 h (in the absence of methionine) 
resulted in abundant labeling of newly synthesized proteins in somata and dendritic 
processes (Fig. 2a, first and third rows from top) at comparable levels for both AHA and 
HPG. Importantly, when protein synthesis was prevented by co–application of the protein 
synthesis inhibitor anisomycin, the fluorescent signal was dramatically reduced (Fig. 2a, 
second and fourth rows from top) confirming that this procedure labeled newly synthesized 
proteins with high specificity. Moreover, to further test the specificity of the approach we 
either omitted the copper catalyst in the click reaction mixture or co–applied methionine at 
an equimolar concentration, which prevented detection or incorporation, respectively, of 
AHA and HPG–derived signals (Supplementary Fig. 2). Following the click reaction, 
neurons can also be processed for conventional immunocytochemistry; we demonstrated this 
by immunolabeling with the dendritic marker MAP2 in AHA– or HPG–treated neurons (Fig. 
2a). The combination of FUNCAT with immunolabeling did not alter the FLA or TRA 
signal intensity or result in crosstalk of the red and green image acquisition channels.
Following a 1 h incubation with either AHA or HPG, newly synthesized proteins were 
detected in both the somata and dendrites. Longer (∼2 h) exposures to AHA or HPG 
revealed the presence of newly synthesized proteins in spine–like protrusions from dendrites 
(Fig. 2b). This signal likely represents the presence of newly synthesized proteins at 
synapses as evidenced by proximity to the presynaptic protein Bassoon. Notably, we did not 
detect any changes in neuronal morphology in somata or dendrites, nor elevated levels of 
cell death, indicating no apparent toxicity resulting from AHA and HPG incubation for any 
concentration or methionine starvation period tested (see also ref.22). Taken together, these 
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data indicate that non–canonical amino acids coupled to fluorescent tags via click chemical 
reactions can be used to visualize newly synthesized proteins with high specificity.
We next examined if visualization of newly synthesized proteins can be performed in intact 
tissue using organotypic hippocampal slices. We increased the duration of exposure to AHA 
(to 4 h) to allow penetration of the amino acid into the depth of the slice (ca. 150 µm thick). 
As demonstrated in Supplementary Fig. 3, AHA–tagged proteins are present in somata and 
dendrites throughout the entire slice following labeling with AHA for 4 h. Application of the 
protein synthesis inhibitor anisomycin (40 µM) together with AHA completely blocked the 
fluorescent signal, indicating that protein synthesis is required for the fluorescence 
visualization. In Supplementary Fig. 3, the combination of FUNCAT with immunolabeling 
for MAP2 showed that newly synthesized proteins detected in organotypic slices are present 
in both the cell bodies and the dendrites of hippocampal neurons. The remaining FUNCAT 
signal that is not accounted for by the somatic and dendritic label likely is due to new 
protein synthesis in axons and glia based on immunostaining experiments using the axonal 
marker Tau (Supplementary Fig. 4) and the astroglial marker GFAP in dissociated cortical 
cultures (DC Dieterich, unpublished observations).
In order to examine the effects of a particular treatment on a proteome, it is often desirable 
to conduct pulse–chase type experiments in which two different time intervals can be 
examined. As there are currently two different non–canonical amino acids available, we 
investigated the feasibility of sequential application of AHA and HPG, followed by a click 
reaction with their complementary fluorescent TRA and FLA tags. There were two major 
considerations to adapt the technique for two intervals of labeling: first, optimization of the 
loading and incorporation of both AHA and HPG and second, optimization of the tag 
brightness, taking into consideration bleaching and the extended period of time from 
labeling to imaging. We tested all possible sequences of labeling (first AHA then HPG, or 
first HPG then AHA) and detection (TRA or FLA tag). For example, neurons were treated 
with HPG for 1 h and then washed and treated with AHA for 1 h. Following AHA treatment, 
neurons were fixed and exposed first to the FLA tag (overnight), followed by thorough 
rinses with PBS containing no EDTA to remove unligated tag, and then to the TRA tag 
(again, overnight) (or vice versa). This resulted in the fluorescent labeling of two distinct 
proteomes, synthesized in sequential time periods (Fig. 3) that was completely abolished if 
anisomycin was present during the application of AHA and HPG (data not shown). We 
analyzed the TRA and FLA signals in both the somatic and dendritic compartments and 
compared the label intensities for the different labeling orders. We found that application of 
HPG prior to labeling with AHA yielded the brightest and most consistent labeling (see also 
Supplementary Fig. 5); this fits with in vitro observations that charging of HPG onto 
methionyl tRNA is slower than charging of AHA16. Therefore, by using HPG in the first 
pulse followed by the AHA pulse the slower charging rate can be neglected. In addition, we 
determined that ligation of the TRA tag prior to the FLA tag is preferable, most likely since 
the TexasRed dye is less prone to photo degradation and bleaching than the fluorescein 
fluorophore24, a fact that might be overcome by using fluorophores with the same stability 
features. Thus, the optimal sequential tagging strategy for labeling two intervals of protein 
synthesis is HPG then AHA then TRA then FLA. This approach, coupled with a period of 
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stimulation, should provide an informative means to visualize changes in neuronal protein 
synthesis.
Sensitivity of FUNCAT
To investigate how quickly newly synthesized proteins can be visualized, we performed a 
time–course experiment, varying the duration of exposure to either AHA or HPG. To 
capture early events of translation we imaged neurons with high resolution after FUNCAT 
and MAP2 immunostaining. We analyzed the signal intensities of newly synthesized 
proteins of straightened dendrites using the MAP2–defined area as a mask. Strikingly, newly 
synthesized proteins can be detected in neuronal somata following a brief 10 min AHA or 
HPG exposure (Fig. 4a,b; Supplementary Fig. 6, respectively). Increasing the duration of 
AHA or HPG exposure resulted in a more intense fluorescent signal in cell bodies and the 
emergence of signal in the dendrites. Newly synthesized proteins in proximal dendrites were 
visible as early as 20 min after incubation (Fig. 4c,d), with signals increasing in intensity 
and expanding into distal dendritic segments within 2 h. We compared the relative efficacy 
of AHA and HPG and found no difference in tagging performance for AHA or HPG for 
time points over 30 min. However, for early time points (10 min and 20 min) AHA appears 
to be incorporated faster into nascent proteins compared to HPG, again consistent with 
previously published charging rates of AHA and HPG by the methionyl–tRNA synthetase 
(MetRS)16.
Monitoring BDNF–Induced Proteome Dynamics with FUNCAT
Protein translation enables neurons to respond rapidly to changes in the environment or 
activity pattern. BDNF (brain–derived neurotrophic factor) is an important modulator of 
neuronal activity during development as well as in the adult organism, and has been 
implicated in regulating neuronal survival, signaling and activity–dependent synaptic 
plasticity25. Moreover, it has been shown that BDNF elicits a protein synthesis dependent 
enhancement of synaptic strength12,26. In addition, BDNF induced an increase in dendritic 
translation of a GFP–based reporter construct in mechanically and optically isolated 
dendrites12. To examine the effects of synaptic stimulation on protein translation and on the 
localization of newly synthesized proteins, we performed bath application experiments with 
BDNF in the presence of AHA, followed by detection of AHA–harboring proteins with 
FUNCAT. In these experiments, we detected a 1.6–fold increase in the signal of newly 
synthesized proteins in proximal segments of BDNF–treated dendrites over controls 
(vehicle) after bath application of BDNF (50 ng/ml) for 1 h (Fig. 5a,b). In these experiments, 
the distal dendrites showed a less BDNF–induced increase in translation that may be 
attributed to the low signal–to–noise ratio associated with fluorescence imaging in tiny 
processes. These data demonstrate that FUNCAT can be used to visualize changes in protein 
synthesis in intact neurons.
Exploring the site of translation
The above experiments, in which AHA or HPG was introduced in the bath, do not address 
the site (somata or dendrites) of protein synthesis. To examine dendritic protein synthesis in 
a context where somatic synthesis is minimized, we locally perfused a protein synthesis 
inhibitor over a neuronal cell body while AHA was applied to the bath. To examine whether 
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the non–canonical amino acids can be taken up across dendritic membranes and locally 
incorporated into proteins, we examined the localization of the amino acid transporter LAT1 
and MetRS. Both proteins were detected in the somata and dendrites, exhibiting a punctate 
distribution pattern (Supplementary Fig. 7). Using small delivery and suction pipettes, we 
microperfused anisomycin over the soma while AHA was bath–applied in the presence or 
absence of BDNF (Fig. 6a). 30 min after addition of AHA (or AHA + BDNF) to the bath, 
we fixed and processed cells for FUNCAT staining and MAP2 immunostaining. As 
previously observed, BDNF enhanced the new protein synthesis signal in both the cell 
bodies and the dendrites (Fig. 6b,c). We then addressed the contribution of somatic protein 
synthesis to this enhancement by introducing the perfusion of anisomycin over cell bodies. 
The somatic perfusion of anisomycin diminished the signal intensity of newly synthesized 
proteins in the soma to levels comparable to that observed when anisomycin and AHA were 
bath applied (Fig. 6b). These data suggest that the local perfusion of anisomycin is as 
effective as bath application in inhibiting protein synthesis. Interestingly, the distal segments 
of dendrites from neurons perfused at the soma with anisomycin exhibited AHA–derived 
intensity levels that were comparable to dendrites from nonperfused neurons (compare green 
bars in Fig. 6c to purple bars in Fig. 6d), suggesting a dendritic synthesis source for this 
AHA–derived signal. Moreover, as observed previously (e.g. Fig. 5), the addition of BDNF 
resulted in an increase of translation over the entire dendrite. Statistical analysis (one–way 
ANOVA with post–hoc Tukey multiple comparison testing) revealed a significant main 
effect both of treatment and dendritic segment; the interaction was also significant (p = 
0.0125 for the first proximal 100 µm, and p = 0.0473 for the second 100 µm).
To examine directly whether non–canonical amino acids can be locally incorporated into 
proteins synthesized in dendrites, we selectively microperfused AHA onto single distal 
dendrites (Fig. 7a). In these experiments, we combined local dendritic microperfusions with 
bath application of anisomycin to reduce the likelihood of 2 events: i) AHA incorporation 
into proteins at sites adjacent to the dendritic perfusion area (due to possible intracellular 
diffusion of AHA; Fig. 7b) and ii) retrograde transport of AHA to the soma followed by 
incorporation of AHA into somatically synthesized proteins. When compared to 
nonperfused dendrites (Fig. 7b,c), the local perfusion of AHA led to detectable de novo 
protein synthesis in dendrites, inside as well as outside of the perfused area. Signal for newly 
synthesized proteins, however, was more prominent within the perfused area with a slight 
gradient of intensity towards the soma. The latter observation might be explained by 
retrograde transport of AHA–labeled proteins to the soma (synapse to nucleus 
communication) as well as the geometrical properties of the dendrite itself. As predicted, 
co–perfusion of AHA and BDNF (50 ng/ml) resulted in an increase in dendritic translation 
(ranging from 1.2 – 1.7 fold). Moreover, newly synthesized proteins were found to a larger 
extent in regions adjacent to the perfused area, indicating that local application of the 
neurotrophin also may affect the translation in or diffusion to neighboring synaptic regions. 
To exclude the possibility that local microperfusion itself exerts these effects, we repeated 
the last experiment in combination with AHA bath application (Supplementary Fig. 8). 
Here, microperfusion of AHA results in negligible changes in protein translation, whereas 
local co–application of BDNF produced a pronounced increase in de novo protein synthesis.
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Diffusion properties of new proteins at neuronal membranes
In the previous experiments, the copper–dependent click reaction that couples the newly 
synthesized proteins to our fluorescent tags required fixation of the sample. We next 
analyzed the mobility of individual newly synthesized proteins in the membrane of living 
neurons, using Single Particle Tracking (SPT) experiments in which Quantum dots (QDs) 
were coupled to membrane proteins tagged with AHA (Fig. 8a). Given their brightness and 
photostability, QD nanoparticles are powerful fluorescent probes for SPT27. After a brief (∼ 
30 min) methionine deprivation, neurons were incubated with AHA, Met or AHA + 
anisomycin for 2–4 hours to allow new proteins to be synthesized and trafficked to the cell 
surface. The detection of AHA–labeled proteins in living cells involved the use of a copper–
free click chemistry method28, based on the covalent coupling of the azide group of AHA–
tagged proteins with an alkyne–bearing reagent, a difluorinated cyclooctyne (DIFO), a 
membrane impermeant reagent. Subsequently, neurons were incubated in DIFO–biotin 
derivative, washed, and labeled with streptavidin–conjugated Quantum Dots (QD–SA) for 1 
min.
As shown in Fig. 8b, QD labeling in living and non–permeabilized cells resulted in newly 
synthesized AHA–containing, QD–associated proteins detected both on neurites and somata. 
The QD–labeling was specific as a very few QD were associated with the neuronal surface 
in control conditions (Fig. 8b).
We characterized the motions of QD–labeled proteins (Fig. 8c) after trajectory 
reconstruction, and determined their relationship to synapses with FM4–64 staining (Fig. 
8c). The high signal–to–noise ratio of QDs enables one to estimate their position with an 
accuracy of 10–20 nm29. The plot of the mean square displacement (MSD) as a function of 
time indicates the type of movement: at the extrasynaptic membrane, newly synthesized 
proteins had a Brownian–like behavior as indicated by the almost linear MSD vs time plot; 
at synapses, the movement was confined since the plot tended toward an asymptote (Fig. 
8d). The cumulative distribution of diffusion coefficients (D) of newly synthesized proteins 
emphasized the heterogeneity of diffusive behaviors. D values spread over 5 orders of 
magnitude (10−4 <D< 1 µm2/s) with a bimodal distribution (Fig. 8e,f), likely reflecting the 
diversity of synthesized proteins. At extrasynaptic regions, a fast moving population 
(2,5.10−2 <D<1 µm2/s) represented 50% of the trajectories, and a slow one (D<10−3µm2/s) 
represented 35% of the trajectories. AHA–tagged proteins were slower at synapses than 
outside synapses, with a similar number of immobile QDs (65% and 50%, respectively). We 
compared the D distribution of the population of newly synthesized proteins to that of 
defined membrane proteins, such as the γ2–GABAA receptor subunit in hippocampal 
neurons at 15 DIV (Fig. 8e,g). Interestingly γ2–GABAA receptor had a unimodal 
distribution of D with 75% of values between 6.10−3 and 6.10−2 µm2/s (G Gouzer, personal 
communication), spanning only a sub–range of that of the whole pool of newly synthesized 
proteins. This was also the case for the GFP–GPI30, the mGluR531,32 or the AMPAR 
(GluR233). Interestingly, each individual protein had a specific pattern of mobility, which is 
reflected in the distribution of the diffusion coefficients; the diffusion coefficient of the 
newly synthesized proteins, in contrast, spans over the distribution of any individual protein 
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(Fig. 8f). Other parameters such as confinement and dwell time in given compartments were 
distinct as well (data not shown).
DISCUSSION
Synapses possess a complex mixture of proteins including receptors, regulatory and 
scaffolding proteins. Despite a clear need, dynamic visualization of the complete dendritic 
and/or synaptic proteome is still lacking. Indeed, new protein synthesis during synaptic 
plasticity is often inferred from electrophysiological recordings, rather than directly 
visualized or detected4,6,26,34,35. In a few cases, however, the direct visualization of a 
single type of newly synthesized protein has been achieved with great effort12,14,36,37. 
Owing to the techniques used (fluorescent reporters or antibodies) these studies have 
necessarily focused on one or two candidate proteins at a time.
Bioorthogonal chemistry provides an alternative to these methods as it lends novel 
functionality to endogenous proteins using chemical groups that are not readily found in 
living organisms. We demonstrate that a brief (∼10 min) application of either AHA or HPG 
followed by a click reaction with a fluorescent (azide– or alkyne–bearing) tag gives rise to a 
clearly detectable signal in neuronal somata. A slightly longer (∼20 min) exposure to AHA 
or HPG allows one to visualize newly synthesized proteins in dendrites. To visualize newly 
synthesized proteins we developed two fluorescent alkyne probes, TRA and FLA, for 
ligation to AHA– or HPG–labeled proteins. A previous study used HPG together with a 3–
azido–7–hydroxycoumarin tag to visualize newly synthesized proteins in heterologous 
cells38. The TRA and FLA tags are better for tagging newly synthesized proteins in 
dissociated neuronal cultures and organotypic slices compared to the coumarin dye, because 
there is less background labeling associated with the tag sticking to the poly–D–lysine 
coating of the dishes used for culturing dissociated neurons. The synthesis can be easily 
adapted to develop similar PEO–linker featured fluorescent tags using different fluorophores 
to accommodate special needs such as STED high–resolution microscopy. Importantly, the 
recent development of alkyne-tags that can be coupled to azides via strain–promoted 
cycloaddition39 enabled us to examine the spatial dynamics of de novo synthesized 
membrane proteins in real time.
The specific compartment where proteins are synthesized is important for understanding 
both the cell biology and the logic of synaptic function and plasticity. Using microperfusion 
techniques to effect the selective exposure of somata or dendrites to AHA and/or a protein 
synthesis inhibitor we observed the spatial origin of the newly synthesized proteins in both 
cell bodies and dendrites. In future studies this technique can be used to visualize the 
trafficking and destination of proteins synthesized in distinct neuronal compartments. Here, 
the use of microfluidic cell culture devices40 to accommodate the spatially restricted 
delivery of metabolites and reagents may allow one to investigate the contributions of 
somatic and dendritic protein synthesis to synaptic plasticity. For example, there is 
considerable interest in the idea of “synaptic tagging” where synaptic signals stimulate 
transcription and/or translation in the soma and the mRNAs or proteins generated are 
“captured” at those synapses that have been tagged. Thus far, the capture of new proteins 
has been inferred by clever electrophysiological and pharmacological manipulations4,6,41–
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43. The techniques described here would allow one to directly visualize the capture 
phenomenon.
Since the technique works both in dissociated neurons and in brain slices, labeling in vivo 
may also be possible. In this case, the ability to label sub–populations of neurons has distinct 
advantages for both visualization and circuit analysis. We have recently described a new 
system that may permit such visualization44. In this system, a mutant version of the MetRS 
is introduced which incorporates a modified non–canonical amino acid (azidonorleucine; 
ANL) into protein. Cell or promoter–specific labeling can be effected by the selective 
expression of the mutant MetRS in a particular cell population; ANL is not charged by the 
endogenous MetRS and as such will only label proteins in the identified cell population.
The earliest demonstrations that new protein synthesis is important for long–term memory 
were behavioral studies in both rodents45 and fish46. Using modifications of the techniques 
we describe above, we should be able to visualize, directly, protein synthesis in neural 
circuits involved in learning and memory.
Methods
Reagents
We purchased all reagents at ACS grade from Sigma unless noted otherwise. We purchased 
brain–derived neurotrophic factor (BDNF) from Promega, and used it at a concentration of 
50 µg/ml. We purchased HPG from Chiralix (The Netherlands).
Organic Synthesis
We prepared AHA and the triazole ligand as described previously47. We prepared the 
TexasRed–PEO2–Alkyne by dissolving TexasRed–PEO2–propionic acid succinimidyl ester 
(Biotium Inc.) in excess neat propargylamine (Sigma–Aldrich). After 30 min, we added the 
solution dropwise to anhydrous diethyl ether. We collected the resulting precipitate by 
centrifugation (5 min, 10°C, 10.000 × g). Then, we washed the precipitate three times with 
anhydrous diethyl ether, dried and characterized it by ion spray MS to confirm the formation 
of the product with a molecular weight of 802.90 g/mol (Supplementary Fig. 1a). We 
synthesized the azide–bearing fluorescein tag in a similar way using the amine–reactive 5–
carboxyfluorescein–PEO8–propionic acid succinimidyl ester (Biotium Inc.) and 3–
azidopropan–1–amine20 to yield a product with a molecular weight of 881.20 g/mol 
(Supplementary Fig. 1b).
Cultured Hippocampal Neuron and Organotypic Hippocampal Cultures
We prepared and maintained dissociated hippocampal neurons as previously described12. 
Brieﬂy, we dissected out and dissociated hippocampi from postnatal day 0 to 2 rat pups 
(strain Sprague–Dawley) by either trypsin or papain and plated at a density of 40,000 
cells/cm2 onto poly–D–lysine–coated glass–bottom Petri dishes (Mattek). We maintained 
these cultures in Neurobasal A medium containing B–27 and Glutamax supplements 
(Invitrogen) at 37°C for 18–24 days before use. We prepared organotypic hippocampal 
cultures according to Gogolla et al.48, and maintained in culture for three weeks before use.
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Copper–Catalyzed [3+2]–Azide–Alkyne–Cycloaddition Chemistry (CuAAC) and Detection 
of Tagged Proteins
In all culture experiments, we removed the growth medium from neuronal cultures and 
replaced it with either HEPES–buffered solution (HBS)12 or methionine–free Hibernate A 
(HibA) medium (BrainBits LLC.) for 30 min to deplete endogenous methionine. We 
observed no difference in protein synthesis between neuronal cultures incubated in HBS or 
HibA for time points tested (up to 2 hours). However, we opted to use HibA after it became 
available as a defined and customizable minimal neuronal growth media to optimize and 
standardize our labeling procedure. For AHA labeling, we supplemented HBS and HibA 
with 2 mM AHA, 2 mM AHA plus 40 µM anisomycin, or 2 mM methionine. After 
incubation at 37°C, 5% CO2, we washed cells with chilled PBS–MC (1mM MgCl2, 0.1 mM 
CaCl2 in PBS) on ice to remove excess amounts of AHA and methionine followed by 
immediate fixation with chilled 4% paraformaldehyde, 4% sucrose in PBS–MC for 20 min 
at room temperature (RT).
For CuAAC, in order to avoid copper bromide–derived precipitates, we used TCEP in 
combination with copper sulfate to generate the Cu(I) catalyst during the CuAAC reaction. 
Briefly, a CuAAC reaction mix composed of 200 µM triazole ligand (stock solution 
dissolved at 200 mM in DMSO), 2 µM fluorescent alkyne or azide tag, 400 µM TCEP and 
200 µM CuSO4 was mixed in PBS (pH 7.6 ) with vigorous vortexing after each addition of a 
reagent. We incubated hippocampal primary cultures or organotypic hippocampal slices 
overnight at 20°C with the CuAAc reaction mix in a humid box under gentle agitation. 
Following incubation, we washed cells or slices three times for 10 min each at RT with 1% 
Tween–20, 0.5 mM EDTA in 1x PBS pH 7.4 followed by three rinses with 1x PBS pH 7.4 
prior to immunostaining using standard conditions. We tested AHA and HPG concentrations 
ranging from 0.1 mM to 4 mM and observed saturated labeling at a 2 mM concentration 
without any apparent toxicity or any change in gross cellular morphology (data not shown). 
Therefore, we used 2 mM AHA or HPG in all subsequent experiments.
For immunolabeling after AHA incorporation and cycloaddition, we treated primary cells 
sequentially with PBS, blocking solution (0.1% Triton X–100, 2 mg/ml BSA, 5% sucrose, 
10% normal horse serum in PBS), primary Ab in blocking solution at 4°C overnight or at RT 
for 2 h, PBS–Tx (0.1% Triton X–100 in PBS), Alexa488– or Alexa568–conjugated 
secondary Ab (Invitrogen) in blocking solution, PBS–Tx and PBS, and mounted in Gold 
Prolonged Antifade reagent (Invitrogen) prior to imaging. For immunolabeling and 
cycloaddition of AHA–tagged proteins in organotypic cultures, we fixed slices overnight at 
4°C, rinsed extensively several times, blocked and permeabilized overnight in blocking 
solution before performing CuAAC for at least 12 h at RT. We performed immunostaining 
for MAP2 as described above with extensive washes and prolonged incubation periods with 
secondary antibodies. We used the following primary antibodies: rabbit anti–microtubule–
associated protein 2 (anti–MAP2) polyclonal (1:1000, Chemicon), mouse anti–MAP2 
monoclonal antibody (Sigma, 1:500), mouse anti–bassoon monoclonal (1:1000, Stressgen 
Bioreagents Corp.), mouse anti–Tau (1:400, Chemicon), goat anti–LAT1 (L13) polyclonal 
antibody (Santa Cruz, 1:100), rabbit anti–methionyl tRNA synthetase polyclonal antibody 
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(abcam, 1:500). For secondary antibodies, we used anti–rabbit or anti–mouse conjugated 
Alexa Fluor 488, 568, or 647 (1:500; Invitrogen).
Local Perfusions
Local perfusion experiments were performed with an Olympus IX–70 confocal laser–
scanning microscope using Plan–Apochromat 40x/0.95 air or 40x/1.0 oil objectives. We 
excited Alexa 488 with the 488 nm line of an argon ion laser, and collected the emitted light 
between 510 and 550 nm. For restricted treatment of isolated somata or dendritic segments, 
we used a dual micropipette local delivery system. The delivery micropipette was pulled as a 
typical whole–cell recording pipette with an aperture of ∼ 0.5 µm. We controlled the area of 
local perfusion by a suction pipette, using it to draw the treatment solution across one or 
more dendrites and to remove the perfusion solution from the bath. In all microperfusion 
experiments we monitored the dimension of the perfusion spot with the fluorescent dye 
Alexa Fluor 488 hydrazide (1 µg/ml, Invitrogen) throughout the duration of the experiment; 
perfusion spot diameters ranged from 30 to 50 µm). We used only the experiments in which 
the affected area changed by less than 20% for analysis. In all local perfusion experiments, 
we maintained the set–up at 32°C with a closed box–incubator around the microscope and 
used multiple small water pans to keep the system humid. We started somatic perfusions 
with anisomycin (40 µM ) 20 min before bath application of 2 mM AHA or 2 mM AHA + 
BDNF (50ng/ml; 30 min incubation) to decrease somatic translation to minimal levels. After 
fixation, we performed FUNCAT using 1 mM TRA tag and immunostained for MAP2. We 
determined the size of the treated area for each soma or dendrite based on Alexa 488 
fluorescence integrated across all images (typically 6–10) taken during local perfusion
Microscopy and image analysis
Unless otherwise specified, we acquired images with a Zeiss 510 Meta confocal laser 
scanning microscope. We excited Alexa 488 and 5–carboxyfluorescein with the 488 nm line 
of an argon ion laser, and collected the emitted light between 510 and 550 nm. We excited 
TexasRed with the 568 nm line of a krypton ion laser, and collected the emitted light above 
600 nm. In experiments where two channels were acquired simultaneously, we chose 
settings to ensure no signal bleed–through between channels. For between–dish comparisons 
on a given day, we acquired all images using the same settings, without knowledge of the 
experimental condition during image acquisition. We performed all postacquisition 
processing and analysis with ImageJ (NIH) and Imaris (Bitplane Scientific Software). To 
facilitate the analysis of fluorescence signal as a function of distance from the soma, we 
linearized dendrites and extracted their unprocessed full–frame images using the Straighten 
plugin for ImageJ. For the analyses of local perfusion experiments, we calculated the TRA 
signal intensity per volume using a 3D–mask that was generated from the corresponding 
MAP2 stacks of straightened dendrites in 10 µm volume segments using Imaris.
Copper–free click chemistry and single particle imaging
We performed QD experiments on 8–12 DIV hippocampal neurons. First, we deprived cells 
of methionine for 30 min in HBS, and then incubated with HBS supplemented with 2 mM 
AHA, 2 mM AHA + 40 µM anysomycin, or 2 mM methionine for 2–4 hours at 37°C, 5% 
CO2. For the click chemistry reaction, we washed and incubated cells in 1µM DIFO–
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biotin29 for 5 minutes at room temperature (20–25°C). Following 5–10 washes, we then 
incubated coverslips for 1 min at 37°C with streptavidin–coated quantum–dots emitting at 
605 nm (1 nM, Invitrogen) in borate buffer (50 mM) supplemented with sucrose (200 mM). 
We extensively (∼5 times) rinsed cells in HBS and exposed them to KCl (40 mM) and 
FM4–64 (2 µM, Invitrogen) for 30 s to stimulate vesicle recycling at presynaptic sites. We 
then washed and imaged cells in an open chamber mounted on an inverted microscope 
(IX71, 60X objective, NA=1.45, Olympus). We detected QDs and FM4–64 using a Hg+ 
lamp and appropriate excitation and emission filters (QD: D455/70x, HQ605/20m, FM4–64: 
D535/50x, E590lpv2; Chroma Technology). We recorded QDs for 38.5 s at 13Hz (500 
consecutive frames) with a CCD Camera (Cascade 512BFT, Roper Scientific) and 
Metaview (Meta Imaging). Average number of QD per movie in AHA, AHA+Anisomycin 
and Methionine conditions: 25, 3.5 and 6.2s; average number of mobile QDs: 8.3, 3.6, 0.8, 
respectively. For the analysis we did not take into account QDs with D<10−4 µm2/s. We 
performed GABAA receptor experiments on 15 DIV neurons immunolabeled with QDs as 
previously described 49.
Statistics
Results are presented as mean s.d./SEM for the indicated number of experiments. Statistical 
analyses were performed using one–way ANOVA and Student's t–test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Chemical components and FUNCAT procedure
(a) Chemical structures of the modified amino acids azidohomoalanine (AHA) and 
homopropargylglycine (HPG), and the two fluorescent tags TexasRed–PEO2–Alkyne 
(TRA) and 5–carboxyfluorescein–PEO8–Azide (FLA) used in this study to visualize newly 
synthesized proteins. (b) Cartoon illustrating the Cu(I)–catalyzed [3+2] azide–alkyne 
cycloaddition (CuAAC) principle.
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Figure 2. Visualization of newly synthesized proteins in dissociated primary hippocampal 
neurons
(a) Dissociated hippocampal neurons (DIV 17) were incubated with either 2 mM AHA or 2 
mM HPG in the presence or absence of 40 µM anisomycin (Aniso) for 1 h, tagged with 1 
mM TRA or FLA tag and immunostained for the dendritic marker protein MAP2. Scalebar 
= 20 µm. (b) Dissociated neurons were incubated with 2 mM AHA for 2 h followed by 
tagging with 1 mM TRA tag and immunostaining for Bassoon as a synaptic marker. 
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Arrowheads denote spine–like protrusions. Scalebar = 10 µm in the left panel images, 
scalebar = 5 µm in the magnified images.
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Figure 3. Sequential labeling of 2 newly synthesized protein pools with two metabolic markers
(a) Dissociated hippocampal neurons (DIV 16–18) were incubated in 2 mM AHA for 1.5 h 
followed by 4 mM HPG for 1.5 h and vice versa, and sequentially tagged with either 1 mM 
TRA then 1 mM FLA tag, or FLA tag followed by TRA tag for 12 hours each. Scalebar = 20 
µm. Color lookup table indicates fluorescence intensity (pixel intensities 0–255). Labeling 
and detection sequences: A,H, F,T: first AHA then HPG, first FLA then TRA tag; H,A, T,F: 
first HPG then AHA, first TRA then FLA tag. Images were acquired and analyzed using 
identical parameters on a Zeiss Meta 510 confocal microscope using a 40x objective, 
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postprocessing and analysis was done with ImageJ. Graph (b) represents mean intensities ± 
SEM of somata for the indicated labeling and detection sequences. Graph (c) represents 
mean intensities ± SEM of dendrites (0–100 µm) for the indicated tagging and detection 
sequences. White boxes correspond to TRA signals, grey boxes indicate FLA signals. n = 6–
10 neurons. P–values: ** p < 0.005; * p < 0.05.
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Figure 4. Time–course for the detection of newly synthesized proteins in somata and dendrites
(a) Cultures (DIV 16) were incubated for the time points indicated with 2 mM AHA, 2 mM 
methionine (Met) or 2 mM AHA in the presence of 40 µM anisomycin (Aniso). After 
cycloaddition with the fluorescent TRA tag, images were acquired with identical parameters 
on a Zeiss Meta 510 confocal microscope using a 63x objective. Scalebar = 5 µm. Graph (b) 
represents mean intensities ± SEM of the somata. Per time point, data from 20–50 cells were 
collected and analyzed using ImageJ. Representative examples are shown in the right panel. 
(c) Representative straightened dendrites of neurons incubated with 2 mM AHA, 2 mM 
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Methionine (Met) or AHA plus 40 µM anisomycin (Aniso) for time points indicated. Color 
lookup table indicates fluorescence intensity (pixel intensities 0–255). Left: proximal; right: 
distal. Scalebar = 10 µm. Graph (d) represents mean intensities ± SEM of the dendrites in 20 
µm bins. Per time point data from 25–40 dendrites were analyzed. Note, that somatic signals 
are saturated in some cases, in order to optimize the imaging parameters for signal detection 
in distal dendrite segments.
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Figure 5. BDNF–induced increases in protein synthesis
(a) Hippocampal neurons (DIV 16) were incubated for 1 h with 2 mM AHA alone (vehicle 
control) or 2 mM AHA in the presence of 50 ng/ml BDNF. After a 15 min chase with 2 mM 
methionine, cells were fixed, tagged with 1 mM fluorescent tag and immunostained for the 
dendritic marker protein MAP2. For quantitative analysis, dendrites of both groups were 
straightened and fluorescent intensities of binned 40 µm segments were measured using 
ImageJ. Representative images for both groups are shown. Color lookup table indicates 
fluorescence intensity (pixel intensities 0–255). Note the increase in signal intensity in both 
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cell body and dendrites in BDNF–treated versus control cells. Left: proximal; right: distal. 
Scalebar = 20 µm. (b) Graph shows the change of TRA–signal of BDNF–treated cells ± 
SEM normalized to controls (vehicle). P–values: *** p < 0.000005; ** p < 0.005; * p < 
0.05.
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Figure 6. BDNF–induced increase in dendritic protein synthesis
(a) Somata of neurons were perfused with 40µM anisomycin before and during bath-
application of 2 mM AHA, or 2 mM AHA + BDNF (50 ng/ml) for 30 min, scalebar = 50 
µm. (b) Images showing signals of newly synthesized proteins from nonperfused somata 
(top left, AHA (I); top right, AHA + BDNF (II)), anisomycin–perfused somata (bottom left, 
AHA (III); bottom center, AHA + BDNF (IV)) and anisomycin–bath cells (bottom right, 
(V)). n = 6–9 cells. Large grid tick marks = 20 µm. Graph shows TRA–signal to volume 
ratios ± SEM. (c,d) Analysis of newly synthesized proteins in dendrites of groups I–IV. 
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Images show signal intensity of representative dendrites beginning at the soma. Left, 
proximal; right, distal. Color lookup table indicates fluorescence intensity. Note, that 
somatic signals are saturated in some cases, in order to optimize the imaging parameters for 
signal detection in distal dendrite segments. Large grid tick marks = 10 µm. Summary 
graphs shows signal to volume ratios ± SEM. n= 6–9 dendrites. P–values: *** p < 0.001; ** 
p < 0.01; * p < 0.05, one–way ANOVA with Tukey testing. In graph (c) significance values 
for group (I) vs. (V) dendrites are indicated in green, for group (II) vs. (V) in magenta, for 
group (I) vs. (II) dendrites in grey; in graph (d) significance values for group (III) vs. (V) 
dendrites are indicated in violet, for group (IV) vs. (V) in red, for group (III) vs. (IV) in 
grey.
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Figure 7. Local BDNF–induced increase in dendritic protein synthesis
(a) Hippocampal neurons for dendritic local perfusions in combination with anisomycin bath 
application were pre–incubated in 40 µM anisomycin for 20 min during which time the 
micropipettes were positioned. Dendritic local perfusion with 2 mM AHA in the presence or 
absence of BDNF (50 ng/ml) in HibA (with no anisomycin in the perfusion pipette) was 
initiated, and constantly monitored over the perfusion period of 30 min. Scalebar = 50 µm. 
Images (b) show TRA signals of representative dendrites from groups (I, top) no perfusion, 
(II, center) AHA perfusion, (III, bottom) BDNF plus AHA perfusion. Grey bars mark the 
Dieterich et al. Page 26
Nat Neurosci. Author manuscript; available in PMC 2011 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
location and extension of the perfusion stream. Large grid tick marks = 10 µm. Color lookup 
table indicates fluorescence intensity. Graph (c) shows TRA–signal to volume ratios ± SEM. 
Colored ovals represent the positions of the perfusion spots. n= 4–5 dendrites. P–values: *** 
p < 0.001; ** p < 0.01; * p < 0.05 using one–way ANOVA statistical analysis with Tukey 
testing. Significance values are indicated for the dendritic segments before, within and 
beyond the perfusion spots; violet labels indicate significances for dendrites derived from 
group (I) vs. (II), red labels indicate significance values for group (I) vs. (III) dendrites, grey 
labels indicate significances for group (II) vs. (III) dendrites.
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Figure 8. Diffusion properties of newly synthesized proteins at the surface of dissociated primary 
hippocampal neurons
(a) Strategy for labeling newly synthesized proteins inserted in the membrane of living 
neurons. (b) Neurons were incubated with either 2mM AHA in the presence or the absence 
of anisomycin, or 2mM Methionine for 2–4 hours and labeled with DIFO–biotin and QD–
SA. DIC (left) and QD labeling (right) of live neurons from each condition. Scalebar = 5µm. 
(c) Example of trajectories of newly synthesized proteins labeled with QDs. Left, DIC and 
QD labeling (green); active synapses are visualized with FM4–64; right, Individual 
Dieterich et al. Page 28
Nat Neurosci. Author manuscript; available in PMC 2011 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
trajectories reconstructed from QDs. Synaptic (yellow) and extrasynaptic (blue) trajectories 
were classified in relation to active presynaptic terminals labeled with FM4–64. Scalebar = 
2µm. (d) Average MSD of synaptic and extrasynaptic QDs as a function of time. Values are 
mean ±SEM. (e) Cumulative distribution of newly synthesized proteins diffusion 
coefficients at (n=101) and outside (n=262) synapses (Kolmogorov–Smirnov test, p<0,001). 
The diffusion coefficients of the γ2–GABAAR subunit at synapses (n=212) and at 
extrasynaptic sites (n=77) (KS test, p<0,001) were plotted for comparison. (f) Frequency 
distribution of extrasynaptic diffusion coefficients of newly synthesized proteins. Colored 
bars correspond to the 75% of the values (12,5%–87,5% range, black squares correspond to 
the mode of the distribution) of D values for AMPAR (purple, 50), GABAAR (red), 
mGluR5 (green, 31,32) and GFP–GPI (grey, 30). (g) Frequency distribution of extrasynaptic 
diffusion coefficients of γ2–GABAAR. The red bar on the x-axis corresponds to 75% of the 
values (12,5%–87,5% range) of γ2–GABAAR diffusion coefficients.
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